首页> 美国卫生研究院文献>Reviews in Urology >Open Versus Laparoscopic Versus Robot-Assisted Laparoscopic Prostatectomy: The European and US Experience
【2h】

Open Versus Laparoscopic Versus Robot-Assisted Laparoscopic Prostatectomy: The European and US Experience

机译:开放式与腹腔镜与机器人辅助式腹腔镜前列腺切除术:欧美经验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Open radical prostatectomy (ORP) is the reference standard for the surgical management of localized prostate cancer. With wider availability of minimally invasive radical prostatectomy techniques, there is a debate regarding the standard treatment of the management of localized prostate cancer. Therefore, we reviewed the current status of laparoscopic radical prostatectomy (LRP) and robotic-assisted laparoscopic radical prostatectomy (RALRP) as compared with ORP. Because no prospective, randomized trials comparing the different techniques have been performed, outcomes must be assessed from published series by centers that focus on ORP, LRP, and RALRP. Aside from reducing the amount of blood loss, current data suggest that the most significant outcomes (cure, continence, and potency) are no better with LRP or RALRP than with conventional ORP. Therefore, in experienced hands, ORP remains the gold standard procedure. However, there is a trend toward consistently better outcomes following RALRP in comparison with LRP. In the end, individual patient outcomes can be maximized by choosing the best modality based on the patient’s comorbid medical conditions, cancer characteristics, and surgeon experience. Future studies are needed to further investigate long-term cancer control as well as functional outcomes for RALRP series.
机译:开放式前列腺癌根治术(ORP)是局部前列腺癌外科治疗的参考标准。随着微创根治性前列腺切除术技术的广泛应用,关于局部前列腺癌治疗的标准治疗存在争议。因此,我们回顾了腹腔镜根治性前列腺切除术(LRP)和机器人辅助腹腔镜根治性前列腺切除术(RALRP)与ORP的现状。由于尚未进行比较不同技术的前瞻性随机试验,因此必须由专注于ORP,LRP和RALRP的中心从已发表的系列中评估结果。除了减少失血量,目前的数据表明,LRP或RALRP的最重要结局(治愈,节制和有力)并不比传统ORP好。因此,在经验丰富的人手中,ORP仍然是金标准程序。但是,与LRP相比,RALRP后存在一种始终如一的更好结果的趋势。最后,可以根据患者的合并症,癌症特征和外科医生的经验来选择最佳的治疗方式,从而最大限度地提高个体患者的治疗效果。需要进一步的研究来进一步研究RALRP系列的长期癌症控制和功能结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号